| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 151 |
| 1 | TACROLIMUS | 130 |
| 2 | RITUXIMAB | 127 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 127 |
| 4 | TACROLIMUS OINTMENT 0.1% | 127 |
| 5 | METHOTREXATE SODIUM | 122 |
| 6 | METHOTREXATE | 115 |
| 7 | MYCOPHENOLATE MOFETIL | 99 |
| 8 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 99 |
| 9 | CYCLOPHOSPHAMIDE | 89 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DENILEUKIN DIFTITOX-CXDL | 1 | 0.1000 |
| 1 | NARSOPLIMAB | 1 | 0.0476 |
| 2 | LIGHT MINERAL OIL, WHITE PETROLATUM | 1 | 0.0312 |
| 3 | ONASEMNOGENE ABEPARVOVEC-XIOI | 17 | 0.0074 |
| 4 | BRINCIDOFOVIR | 1 | 0.0072 |
| 5 | DEXTROSE AND SODIUM CHLORIDE | 1 | 0.0060 |
| 6 | CHOLIC ACID | 2 | 0.0050 |
| 7 | FLUORIDE TOOTHPASTE | 1 | 0.0050 |
| 8 | ANORECTAL OINTMENT | 1 | 0.0046 |
| 9 | HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN | 2 | 0.0041 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 326 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 153 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 114 |
| 3 | Alkylating Drug [EPC] | 103 |
| 4 | Kinase Inhibitor [EPC] | 79 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 69 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 65 |
| 7 | Benzodiazepine [EPC] | 53 |
| 8 | Proton Pump Inhibitor [EPC] | 49 |
| 9 | Anti-epileptic Agent [EPC] | 46 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD25-directed Cytotoxin [EPC] | 1 | 0.1000 |
| 1 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 2 | Antisense Oligonucleotide [EPC] | 28 | 0.0023 |
| 3 | Ileal Bile Acid Transporter Inhibitor [EPC] | 1 | 0.0022 |
| 4 | Carnitine Analog [EPC] | 8 | 0.0022 |
| 5 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 8 | 0.0019 |
| 6 | CD38-directed Cytolytic Antibody [EPC] | 10 | 0.0017 |
| 7 | Enzyme Stabilizer [EPC] | 2 | 0.0017 |
| 8 | Asparagine-specific Enzyme [EPC] | 23 | 0.0017 |
| 9 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 36 | 0.0016 |